ArticleInternational ophthalmology2021
Analysis of trending topics in glaucoma articles from an altmetric perspective.
Article in International ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- From tumor microenvironment to ocular hypertension: unraveling the pathogenesis and therapeutic strategies of cancer-related glaucoma.Frontiers in medicine · 2025Review
- Top 50 most-cited articles on SMILE surgery between 2010 and 2022: a correlation comparison between conventional bibliometrics and current altmetrics of research impact.International ophthalmology · 2023Article
- Altmetric and Bibliographic Analysis of the Most Popular Articles on Vitreoretinal Surgery Between 2010 and 2020.Cureus · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAltmetric analyses are a new way of assessing and sharing scientific knowledge. Traditional metrics and altmetric analyses highlight key publications. The primary objective of this study was to evaluate the social attention paid to highly cited articles related to glaucoma in the recent English literature and compare with traditional citation metrics. MATERIALS AND
methods"Glaucoma" was entered as a search term into Thomson Reuter's Web of Science database, and all articles related to the topic in the last decade were identified. The 50 highly cited articles (T50 list) were analyzed by topic, journal name, author name, year of the publication and Altmetric Attention Score (AAS). Descriptive statistics and Spearman correlation test were determined with the use of SPSS.
resultsAccording to bibliometric criteria, there were 31,370 eligible articles and the median (range) citation number was recorded as 181.5 (158.75-250.75). The T50 list was ranked with AASs between 176 and 0. The median AAS was 5 (2.75-10). The main subjects of the top 10 highly cited articles were mostly related to follow-up and prognostics about glaucoma (n = 3), while the main subjects of the top 10 articles with the highest AAS were related to genetics in glaucoma pathogenesis (n = 2), treatment modalities (n = 2) and pathophysiology with therapeutics of glaucoma disease (n = 2). AASs and citation number showed a positive moderate correlation (r = 0.403 p = 0.004), although AASs did not correlate with journal impact factor (r = 0.36 p = 0.01). No statistically significant correlation was found for ASSs and citation numbers with H-index of the journals on the T50 list.
conclusionsBibliometric-based altmetric analyses offer important but different perspectives regarding article impact. This study provides valuable information about trending topics related to glaucoma research and its impact in both the academic literature and social media CLINICAL
trial registrationWith regard to the data characteristics of the manuscript, which is mainly retrospective and international, the clinical trial registration process is theoretically not applicable to this study.
Indexed as
Identifiers
33928474What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.